Guidelines of the Belgian Hematology Society for imaging in multiple myeloma.

Despite major improvements in the diagnosis and treatment of multiple myeloma (MM), bone damage remains a major feature of this disease. With the development of new diagnostic tools, conventional skeletal studies have been progressively replaced by novel imaging techniques. Today, imaging plays a crucial role in defining symptomatic multiple myeloma, measurement of the extent of skeletal involvement and assessing therapeutic response including minimal residual disease (MRD). Based on an extensive review of the recent literature, we propose an array of Belgian recommendations for myeloma imagin... Mehr ...

Verfasser: MEULEMAN, N
CAERS, J
FOSTIER, K
VLUMMENS, P
PANS, S
GOETHALS, L
ALEXIOU, J
CLIQUENNOIS, M
Doyen, Chantal
Dokumenttyp: Artikel
Erscheinungsdatum: 2021
Verlag/Hrsg.: Ariez International B.V.
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-28876758
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/2078.1/258225

Despite major improvements in the diagnosis and treatment of multiple myeloma (MM), bone damage remains a major feature of this disease. With the development of new diagnostic tools, conventional skeletal studies have been progressively replaced by novel imaging techniques. Today, imaging plays a crucial role in defining symptomatic multiple myeloma, measurement of the extent of skeletal involvement and assessing therapeutic response including minimal residual disease (MRD). Based on an extensive review of the recent literature, we propose an array of Belgian recommendations for myeloma imaging to be used as a reference by haematologists in their daily practice.